Clinical trial · Interventional
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection -a Prospective Randomized Controlled Study
NCT01914692CI-TRIAL-00011539completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node dissection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer After D2 Lymph Node Dissection | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Somatostatin | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Somatostatin group
- description
- Patients with Advanced Gastric Cancer After D2 Lymph Node Dissection accept the Somatostatin medical therapy.
- interventionNames
- Drug: Somatostatin
- type
- PLACEBO_COMPARATOR
- label
- Blank group
- description
- Use the normal saline instead of somatostatin.
Primary outcomes (1)
- measure
- fistula of pancreas
- timeFrame
- one year
- description
- number of patients
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. More than eighteen years old 2. Gastric cancer diagnosed by pathological examination 3. Be given informed consent 4. Without diabetes/hyperthyroidism/Damages of functions of heart, liver and kidney/Systemic Infection/immunodeficiency Exclusion Criteria: 1. Contraindication of vascular puncture operation 2. Patients who refused to take part in the programe 3. Poor compliance of treatment 4. Malnutrition,BMI\<18 5. with pancreatectomy
References
Publications (0)
Data not yet available
No reference posted for this study.